C-VISA BikDD: Liposome in Advanced Pancreatic Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The goal of this clinical research study is to find the highest tolerable dose of BikDD nanoparticle that can be given to patients with advanced cancer of the pancreas. The safety of this drug will also be studied.
Epistemonikos ID: 88308d2021bcf4b0a6130a981ba0e9c6653e24ec
First added on: May 05, 2024